MedTrace Logo

Individuals on Hormone Therapy Breast Cancer Screening Pilot

NCT06383026 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-09-23

No results posted yet for this study

Summary

This investigation is a prospective breast cancer screening study open to all individuals on hormone therapy. Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with hormone therapy and family cancer history and 2) investigate individuals on hormone therapy perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening.

Conditions

Interventions

DIAGNOSTIC_TEST

Breast Cancer Screening

Screening mammography as well as whole breast ultrasound interpreted by BI-RADS.

OTHER

Survey/Interview

A mixed-methods approach including electronic surveys and one on one interviews.

OTHER

Focus Group

A semi-structured focus group with open-ended questions that explores faculty and staff experiences in a breast cancer screening program for individuals on hormone therapy.

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Chandler S Cortina, MD, MS · The Medical College of Wisconsin

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-17
Primary Completion
2027-12-31
Completion
2028-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383026 on ClinicalTrials.gov